Correlation Between TTY Biopharm and Ruentex Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TTY Biopharm and Ruentex Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TTY Biopharm and Ruentex Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TTY Biopharm Co and Ruentex Development Co, you can compare the effects of market volatilities on TTY Biopharm and Ruentex Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TTY Biopharm with a short position of Ruentex Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of TTY Biopharm and Ruentex Development.

Diversification Opportunities for TTY Biopharm and Ruentex Development

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between TTY and Ruentex is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding TTY Biopharm Co and Ruentex Development Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ruentex Development and TTY Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TTY Biopharm Co are associated (or correlated) with Ruentex Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ruentex Development has no effect on the direction of TTY Biopharm i.e., TTY Biopharm and Ruentex Development go up and down completely randomly.

Pair Corralation between TTY Biopharm and Ruentex Development

Assuming the 90 days trading horizon TTY Biopharm Co is expected to under-perform the Ruentex Development. But the stock apears to be less risky and, when comparing its historical volatility, TTY Biopharm Co is 2.63 times less risky than Ruentex Development. The stock trades about -0.01 of its potential returns per unit of risk. The Ruentex Development Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,610  in Ruentex Development Co on August 29, 2024 and sell it today you would earn a total of  890.00  from holding Ruentex Development Co or generate 24.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

TTY Biopharm Co  vs.  Ruentex Development Co

 Performance 
       Timeline  
TTY Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TTY Biopharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Ruentex Development 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ruentex Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

TTY Biopharm and Ruentex Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TTY Biopharm and Ruentex Development

The main advantage of trading using opposite TTY Biopharm and Ruentex Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TTY Biopharm position performs unexpectedly, Ruentex Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ruentex Development will offset losses from the drop in Ruentex Development's long position.
The idea behind TTY Biopharm Co and Ruentex Development Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios